Zamora I - Search Results

1

Legacy data sharing to improve drug safety assessment: the eTOX project.

Sanz F, Pognan F, Steger-Hartmann T, Díaz C; eTOX; Cases M, Pastor M, Marc P, Wichard J, Briggs K, Watson DK, Kleinöder T, Yang C, Amberg A, Beaumont M, Brookes AJ, Brunak S, Cronin MTD, Ecker GF, Escher S, Greene N, Guzmán A, Hersey A, Jacques P, Lammens L, Mestres J, Muster W, Northeved H, Pinches M, Saiz J, Sajot N, Valencia A, van der Lei J, Vermeulen NPE, Vock E, Wolber G, Zamora I. Sanz F, et al. Among authors: zamora i. Nat Rev Drug Discov. 2017 Dec;16(12):811-812. doi: 10.1038/nrd.2017.177. Epub 2017 Oct 13. Nat Rev Drug Discov. 2017. PMID: 29026211 Free article.

2

Suitability of GRIND-based principal properties for the description of molecular similarity and ligand-based virtual screening.

Durán A, Zamora I, Pastor M. Durán A, et al. Among authors: zamora i. J Chem Inf Model. 2009 Sep;49(9):2129-38. doi: 10.1021/ci900228x. J Chem Inf Model. 2009. PMID: 19728739

3

Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors.

Fontaine F, Pastor M, Zamora I, Sanz F. Fontaine F, et al. Among authors: zamora i. J Med Chem. 2005 Apr 7;48(7):2687-94. doi: 10.1021/jm049113+. J Med Chem. 2005. PMID: 15801859

4

SHOP: a method for structure-based fragment and scaffold hopping.

Fontaine F, Cross S, Plasencia G, Pastor M, Zamora I. Fontaine F, et al. Among authors: zamora i. ChemMedChem. 2009 Mar;4(3):427-39. doi: 10.1002/cmdc.200800355. ChemMedChem. 2009. PMID: 19152365

5

Shaping the future of safer innovative drugs in Europe.

Mestres J, Bryant SD, Zamora I, Gasteiger J. Mestres J, et al. Among authors: zamora i. Nat Biotechnol. 2011 Sep 8;29(9):789-90. doi: 10.1038/nbt.1973. Nat Biotechnol. 2011. PMID: 21904315 No abstract available.

6

Surface descriptors for protein-ligand affinity prediction.

Zamora I, Oprea T, Cruciani G, Pastor M, Ungell AL. Zamora I, et al. J Med Chem. 2003 Jan 2;46(1):25-33. doi: 10.1021/jm011051p. J Med Chem. 2003. PMID: 12502357

7

Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

Radchenko T, Brink A, Siegrist Y, Kochansky C, Bateman A, Fontaine F, Morettoni L, Zamora I. Radchenko T, et al. Among authors: zamora i. PLoS One. 2017 Nov 1;12(11):e0186461. doi: 10.1371/journal.pone.0186461. eCollection 2017. PLoS One. 2017. PMID: 29091918 Free PMC article.

8

Software-aided workflow for predicting protease-specific cleavage sites using physicochemical properties of the natural and unnatural amino acids in peptide-based drug discovery.

Radchenko T, Fontaine F, Morettoni L, Zamora I. Radchenko T, et al. Among authors: zamora i. PLoS One. 2019 Jan 8;14(1):e0199270. doi: 10.1371/journal.pone.0199270. eCollection 2019. PLoS One. 2019. PMID: 30620739 Free PMC article.

9

Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery.

Cece-Esencan EN, Fontaine F, Plasencia G, Teppner M, Brink A, Pähler A, Zamora I. Cece-Esencan EN, et al. Among authors: zamora i. Rapid Commun Mass Spectrom. 2016 Jan 30;30(2):301-10. doi: 10.1002/rcm.7429. Rapid Commun Mass Spectrom. 2016. PMID: 26689160

10

WebMetabase: cleavage sites analysis tool for natural and unnatural substrates from diverse data source.

Radchenko T, Fontaine F, Morettoni L, Zamora I. Radchenko T, et al. Among authors: zamora i. Bioinformatics. 2019 Feb 15;35(4):650-655. doi: 10.1093/bioinformatics/bty667. Bioinformatics. 2019. PMID: 30052776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page